mailed
on 26 Oct 2023
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
US
07054
Serial Number
97703857 filed on 05th Dec 2022
Registration Number
N/A
Correspondent Address
Laurence RicklesTEVA PHARMACEUTICALS USA, INC.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous Read More
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
No 97703857
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Apr 2024 | SUSPENSION CHECKE - TO ATTORNEY OR ACTION |
26th Oct 2023 | NOTIICATION O LETTER O SUSPENSION E-MAILE |
26th Oct 2023 | SUSPENSION LETTER WRITTEN |
26th Oct 2023 | LETTER O SUSPENSION E-MAILE |
25th Oct 2023 | TEAS/EMAIL CORRESPONENCE ENTERE |
24th Oct 2023 | CORRESPONENCE RECEIVE IN LAW OICE |
24th Oct 2023 | TEAS RESPONSE TO OICE ACTION RECEIVE |
13th Sep 2023 | NOTIICATION O NON-INAL ACTION E-MAILE |
13th Sep 2023 | NON-INAL ACTION E-MAILE |
13th Sep 2023 | NON-INAL ACTION WRITTEN |